As the horizon for the Sustainable Development Goals (SDGs) approaches, progress towards target 3.4 —reducing premature mortality from non-communicable diseases (NCDs) by one-third—remains largely ...

Art isn't just for stages and studios. It can be a powerful public health resource. That's the takeaway from a new ...

The importance of psychological distress in patients with cardiovascular disease is increasingly recognized as both a contributing factor to the development and progression of cardiovascular disease ...

Automated AI analysis of mammogram images combined with age helps predict cardiovascular disease risk, enabling early ...

Explore the Burj Khalifa through this detailed animation created with Blender 3D. The video showcases the architectural ...

Let’s be real: When it comes to detecting heart disease risk, you probably aren’t checking your skin first. And why would you? Skin health and heart health are unrelated, right? Not quite, doctors say ...

– Co-founded by industry leaders John Maraganore, Ph.D., and Clive Meanwell, M.D., pioneers in RNAi and cardiovascular innovation – – Developing Klotho Health, a proprietary AI-enabled tool to predict ...

Industry giants Clive Meanwell, M.D., and John Maraganore, Ph.D., have unveiled Corsera Health, a new biotech aiming to disrupt the cardiovascular landscape with a once-annual preventive heart disease ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

A commonly prescribed drug could be more effective than aspirin for long-term heart disease prevention. Analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests the blood thinner ...

Every 34 seconds, someone in the United States dies from heart disease. As nearly half of the country suffers from some form of cardiovascular disease (CVD), another one in four adults experience a ...